title: Use of fidaxomicin through a nasogastric tube for the treatment of septic shock caused by Clostridium difficile infection in a patient with oral cancer admitted to the Surgical Critical Care Unit.
authors.affiliation: Emilio Maseda, Anesthesiology and Surgical Critical Care Dpt., Hospital Universitario La Paz, Paseo de la Castellana 261, 28046 Madrid, Spain. emilio.maseda@gmail.com.
authors.forename: Emilio
authors.initials: E
authors.lastname: Maseda
authors.forename: Carmen
authors.initials: C
authors.lastname: Hernandez-Gancedo
authors.forename: Araceli
authors.initials: A
authors.lastname: Lopez-Tofiño
authors.forename: Alejandro
authors.initials: A
authors.lastname: Suarez-de-la Rica
authors.forename: Silvia
authors.initials: S
authors.lastname: Garcia-Bujalance
authors.forename: Fernando
authors.initials: F
authors.lastname: Gilsanz
mesh_terms: D000368:Aged; D000617:Aminoglycosides / Q000008:administration & dosage* / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000150:complications / Q000188:drug therapy; D016360:Clostridioides difficile; D003422:Critical Care / Q000379:methods; D003428:Cross Infection / Q000188:drug therapy; D004761:Enterocolitis, Pseudomembranous / Q000188:drug therapy* / Q000382:microbiology; D005260:Female; D000077732:Fidaxomicin; D006801:Humans; D007441:Intubation, Gastrointestinal; D008339:Mandibular Neoplasms / Q000150:complications / Q000188:drug therapy; D009062:Mouth Neoplasms / Q000150:complications*; D009336:Necrosis; D012772:Shock, Septic / Q000188:drug therapy* / Q000382:microbiology
chemical_list: D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000077732:Fidaxomicin